Sequence of activated protein c
AssigneeJichi Medical University
InventorsTsukasa OHMORI, Tomoki TOGASHI, Morisada HAYAKAWA, Nobuhiko KAMOSHITA, Yuji KASHIWAKURA, Takafumi HIRAMOTO, Nemekhbayar BAATARTSOGT
Life of this patent
Estimating the term…
Loading patent…
AssigneeJichi Medical University
InventorsTsukasa OHMORI, Tomoki TOGASHI, Morisada HAYAKAWA, Nobuhiko KAMOSHITA, Yuji KASHIWAKURA, Takafumi HIRAMOTO, Nemekhbayar BAATARTSOGT
Estimating the term…
The invention provides a polypeptide or a partial polypeptide thereof, containing an amino acid sequence represented by the formula: A1—A2—A3 (I) wherein A1 is an amino acid sequence comprising an amino acid sequence of a light chain of protein C or a homologue thereof, A2 is an amino acid sequence constituting a self-cleaving site, and A3 is an amino acid sequence comprising an amino acid sequence of a heavy chain of protein C or a homologue thereof, wherein a dimeric protein or partial protein thereof consisting of fragments on the N-terminal side and C-terminal side of the cleavage site of A2, has protein C activity. The polypeptide or partial polypeptide thereof makes it possible to 1) produce activated protein C as a recombinant preparation, and 2) link same to effective gene therapy for protein C deficiency.
A polypeptide or a partial polypeptide thereof,
(canceled)
(canceled)
Dependencies are inferred from the claim text.